Restructuring Charges (Notes)

9 Months Ended

Sep. 30, 2015

Restructuring Charges [Abstract]

Restructuring and Related Activities Disclosure [Text Block]

Restructuring Charges

In the third quarter of 2015, we entered into an agreement with George A. Lopez, M.D, a member of our Board of Directors and a former employee in our research and development department, pursuant to which we bought out Dr. Lopez's right to employment under his then-existing employment agreement. The $1.8 million buy-out will be paid in equal monthly installments until December 2020. Also in the third quarter of 2015, we reorganized our corporate infrastructure, resulting in one-time employee termination benefits and other associated costs. These restructuring actions resulted in a charge of $2.3 million in the third quarter of 2015 which is presented as a separate line item combined with strategic transaction expenses on our condensed consolidated statements of income. The $2.3 million restructuring charge was accrued as of September 30, 2015 and will be paid out monthly until December 2020. Payments that will exceed one year have been accrued under long-term liabilities in our condensed consolidated balance sheet.

In the third quarter of 2014, we reorganized our selling and corporate infrastructure, resulting in a reduction in workforce. We recognized a $2.8 million restructuring charge for one-time employee termination benefits and other associated costs. The restructuring charge is presented on a separate line item in our condensed consolidated statements of income.